Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck

Dynamic contrast-enhanced computed tomography to assess early activity of cetuximab in squamous cell carcinoma of the head and neck

Background. Cetuximab, a monoclonal antibody targeting the Epidermal Growth Factor Receptor (EGFR), has demonstrated activity in various tumor types. Using dynamic contrast-enhanced computed tomography (DCE-CT), we investigated the early activity of cetuximab monotherapy in previously untreated pati...

Full description

Bibliographic Details
Main Authors: Schmitz Sandra, Rommel Denis, Michoux Nicolas, Lhommel Renaud, Hanin François-Xavier, Duprez Thierry, Machiels Jean-Pascal
Format: Article
Language:English
Published: Sciendo 2015-03-01
Series:Radiology and Oncology
Subjects:
cetuximab
head and neck cancer
perfusion
dce-ct
Online Access:https://doi.org/10.2478/raon-2014-0030

Internet

https://doi.org/10.2478/raon-2014-0030

Similar Items